Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
|
IN |
|
S
|
Smart Logistics Global Ltd
NASDAQ:SLGB
|
HK |
|
Byggmax Group AB
STO:BMAX
|
SE |
|
C
|
CRH PLC
NYSE:CRH
|
IE |
|
MetLife Inc
NYSE:MET
|
US |
|
W
|
Walt Disney Co
XMUN:WDP
|
US |
|
Providence Resources PLC
OTC:PVDRF
|
IE |
Wall St Price Targets
GLENMARK Price Targets Summary
Glenmark Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for GLENMARK is 2 367.69 INR with a low forecast of 1 515.41 INR and a high forecast of 2 871.75 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GLENMARK's stock price target?
Price Target
2 367.69
INR
According to Wall Street analysts, the average 1-year price target for GLENMARK is 2 367.69 INR with a low forecast of 1 515.41 INR and a high forecast of 2 871.75 INR.
What is the Revenue forecast for Glenmark Pharmaceuticals Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Glenmark Pharmaceuticals Ltd?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 24%.
What is the Net Income forecast for Glenmark Pharmaceuticals Ltd?
Projected CAGR
38%
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 38%.
